View full meeting coverage »

Eyetube Meeting Coverage:

2018 American Society of Retina Specialists Annual Meeting

 

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Visual Acuity Outcomes in Patients With Persistent DME Receiving Adjunctive Therapy

  Channels: Retina | Posted 7/21/2018

Raj K. Maturi, MD, reviews the key points of a short-term study on the effect of adding dexamethasone intravitreal implant 0.7 mg (Ozurdex, Allergan) to continued ranibizumab (Lucentis, Genentech) treatment in patients with persistent diabetic macular edema (DME).

Allergan • ASRS Vancouver 2018 • Diabetic macular edema, DME • DME • Genentech • OZURDEX • Visual Acuity


2 / 17 Series: 2018 American Society of Retina Specialists Annual Meeting